This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Kaiser Permanente Study: Short-Term Risk Of Hip Implant Failure Higher For Women

Kaiser Permanente's implant registries, which include the Total Joint Replacement Registry, recently won the 2012 annual John M. Eisenberg Patient Safety and Quality Award, sponsored by The National Quality Forum and The Joint Commission. These registries are models of integration across medical centers in nine states and they represent strong partnerships among health plan administration, hospitals and physician medical groups united to improve the quality of care for patients.

This study is part of Kaiser Permanente's ongoing research on joint implants and patient risk factors that can lead to implant revision. In 2010, a Kaiser Permanente study showed that a detailed and standardized national registry of commonly used joint replacement devices could improve patient outcomes and create clinical and financial efficiencies.

The study analysis was funded in part by the Division of Epidemiology, Office of Surveillance and Biometrics, Center for Devices and Radiological Health in the U.S. Food and Drug Administration.

Other study authors included: Christopher F. Ake, PhD, Elizabeth W. Paxton, and Monti Khatod, MD, of the Southern California Permanente Medical Group; Cunlin Wang, MD, PhD, Thomas P. Gross, MD, MPH, Ronald G. Kaczmarek, MD, MPH, and Danica Marinac-Dabic, MD, PhD, of the U.S. Food and Drug Administration; and Art Sedrakyan, MD, PhD of the Weill Medical College of Cornell University.

About Kaiser PermanenteKaiser Permanente is committed to helping shape the future of health care. We are recognized as one of America's leading health care providers and not-for-profit health plans. Founded in 1945, our mission is to provide high-quality, affordable health care services and to improve the health of our members and the communities we serve. We currently serve more than 9 million members in nine states and the District of Columbia. Care for members and patients is focused on their total health and guided by their personal physicians, specialists and team of caregivers. Our expert and caring medical teams are empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, state-of-the-art care delivery and world-class chronic disease management. Kaiser Permanente is dedicated to care innovations, clinical research, health education and the support of community health. For more information, go to: kp.org/newscenter.

For more information: Jacqueline Brown, jacqueline.brown@golinharris.com, 415-318-4361 Albert Martinez, albert.martinez@kp.org, 510-625-2124

SOURCE Kaiser Permanente

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
SYM TRADE IT LAST %CHG

Markets

DOW 18,285.74 +0.34 0.00%
S&P 500 2,130.82 +4.97 0.23%
NASDAQ 5,090.7940 +19.0510 0.38%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs